Joseph D. Lipchitz

FDA Announces Dates For Long-Awaited Public Hearing On Its Regulation Of Off-Label Communications

Amarin/FDA Settlement: A Significant First Amendment Victory For Off-Label Marketing

A New Year's Resolution: Avoid The Rising Tide of Defamation Claims In The Health Care Arena

State Blue Sky Claims Under The Uniform Securities Act Can Be Won By Sellers, But At A Cost